About us Contacts Interactions: 118 620
Drug search by name

Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate and Hemodialysis

Result of checking the interaction of drug Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate and disease Hemodialysis for safety when used together.

Check result:
Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate <> Hemodialysis
Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Emtricitabine is removed by hemodialysis. Following an emtricitabine dose administered 1.5 hours before the hemodialysis session, approximately 30% of the dose was removed over three hours of hemodialysis (blood flow rate of 400 mL/min and a dialysate flow rate of 600 mL/min). Emtricitabine should be administered after hemodialysis.

References:
  • "Product Information. Emtriva (emtricitabine)." Gilead Sciences, Foster City, CA.
Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate

Generic Name: cobicistat / elvitegravir / emtricitabine / tenofovir

Brand Name: Genvoya, Stribild

Synonyms: Cobicistat, elvitegravir, emtricitabine, and tenofovir